|
|
|
After a lethal bird flu virus emerged in Asia, U.S. officials launched an intense effort to build new defenses against a pandemic, including replacing an antiquated vaccine system, which depends on millions of chicken eggs.
SAN DIEGO, Nov. 23, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company has completed the last scheduled follow-up visit for the final patient enrolled in a Phase 2 trial of its...
Investors have opted for future technology in lieu of proven performers during today's session, sending some of the only market-ready small-cap swine flu players lower by -5% or more. As a whole, the Swine and Bird Flu Stocks...
Vical Shares Rise After The Company Says It Will Be Listed On Nasdaq Biotech Index Nov. 23 (AP) SAN DIEGO (AP) - Shares of Vical Inc. rose Monday after the company said it shares will be added to Nasdaq Biotechnology Index in a...
Movers Roundup: AeroVironment Shares Rise On Upgrade, Ciena Climbs After Nortel Delays Auction (AP) Among the stock activity stories for Monday, Nov. 16, from AP Financial News: NEW YORK (AP) - Shares of AeroVironment Inc. rose...
SAN DIEGO, Nov. 16, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will be added to the NASDAQ Biotechnology Index effective with the U.S. market open on Monday, November 23, 2009.
Nov 12, 2009 (SmarTrend(R) Research Reports via COMTEX) -- SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:VICL) at...
GALVESTON, Texas, Nov. 10, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today is presenting a strong rationale advocating the use of DNA vaccine technology for emerging and/or pandemic infectious diseases. At the...
Vical Incorporated (Nasdaq:VICL - News) today is presenting a strong rationale advocating the use of DNA vaccine technology for emerging and/or pandemic infectious diseases. At the University of Texas Medical Branch Symposium,...
by: Michael Steinberg November 09, 2009 | about: Michael Steinberg About this author: ) have been my core biotech holdings since the mid 1990s and I have been steadily adding to these positions each time the market has lost...
